• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2200117 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2022-05-18 Tonghua Dongbao Pharmaceutical Co Ltd view
CYSB2400054 门冬胰岛素注射液 insulin aspart Injection Biological Products Supplementary Application 2024-02-29 Tonghua Dongbao Pharmaceutical Co Ltd view
CYSB2101093 精蛋白人胰岛素混合注射液(40R) human insulin;isophane protamine human insulin Injection Biological Products Supplementary Application 2021-06-17 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSS2200058 利拉鲁肽注射液 liraglutide Injection Biological Products(3.3) New Drug Application 2022-06-09 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSL2200411 德谷胰岛素利拉鲁肽注射液 Insulin Degludec;Liraglutide Injection Biological Products(3.3) New Drug Application 2022-08-29 Tonghua Dongbao Pharmaceutical Co Ltd view
CYSB2400053 门冬胰岛素注射液 insulin aspart Injection Biological Products Supplementary Application 2024-02-29 Tonghua Dongbao Pharmaceutical Co Ltd view
CYHS2200268 恩格列净片 empagliflozin Tablet Chemical Drugs(4) Generic Drug 2022-02-08 Tonghua Dongbao Pharmaceutical Co Ltd view
CYSB2200235 门冬胰岛素注射液 insulin aspart Injection Biological Products Supplementary Application 2022-09-28 Tonghua Dongbao Pharmaceutical Co Ltd view
CYHS2101284 瑞格列奈片 repaglinide Tablet Chemical Drugs(4) Generic Drug 2021-06-11 Tonghua Dongbao Pharmaceutical Co Ltd view
CYSB2200118 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2022-05-18 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSL2400105 德谷胰岛素利拉鲁肽注射液 Insulin Degludec;Liraglutide Injection Biological Products(3.3) New Drug Application 2024-02-07 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSS2101012 门冬胰岛素30注射液 Insulin aspart protamine recombinant;insulin aspart recombinant Injection Biological Products(3.4) New Drug Application 2021-07-14 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSL2200319 德谷胰岛素注射液 insulin degludec Injection Biological Products(3.3) New Drug Application 2022-07-25 Tonghua Dongbao Pharmaceutical Co Ltd view
CYHS2200267 恩格列净片 empagliflozin Tablet Chemical Drugs(4) Generic Drug 2022-02-08 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSS2101010 门冬胰岛素50注射液 Insulin aspart protamine recombinant;insulin aspart recombinant Injection Biological Products(3.4) New Drug Application 2021-07-13 Tonghua Dongbao Pharmaceutical Co Ltd view
CYHS2302353 依托考昔片 etoricoxib Tablet Chemical Drugs(4) Generic Drug 2023-09-02 Tonghua Dongbao Pharmaceutical Co Ltd view
CYSB2200229 门冬胰岛素注射液 insulin aspart Injection Biological Products Supplementary Application 2022-09-15 Tonghua Dongbao Pharmaceutical Co Ltd view
CYSB2200228 门冬胰岛素注射液 insulin aspart Injection Biological Products Supplementary Application 2022-09-15 Tonghua Dongbao Pharmaceutical Co Ltd view
CYSB2400219 门冬胰岛素30注射液 Insulin aspart protamine recombinant;insulin aspart recombinant Injection Biological Products Supplementary Application 2024-08-17 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSL2200318 德谷胰岛素注射液 insulin degludec Injection Biological Products(3.3) New Drug Application 2022-07-25 Tonghua Dongbao Pharmaceutical Co Ltd view